23andMe Launches Parkinson’s Disease Genetics Initiative
Personal Genetics Company to Assemble Online Community of 10,000 Individuals with PD To Drive New Online Research Platform
The initiative takes advantage of the 23andMe web-based platform to create an entirely new way to study complex diseases complicated by gene/environment interactions that are difficult to assess using traditional research mechanisms. By using the Internet to query and interact with the research cohort, this platform significantly increases the efficiency and reduces the cost of recruiting participants and conducting research. The broad reach of the web allows individuals who are not near research centers to contribute and be part of the program. Current customers of 23andMe, who are not PD patients, can also contribute by participating as healthy controls, a built-in efficiency that lowers the overall cost.
“We are excited to offer our patients the opportunity to join the 23andMe Parkinson’s community,” said
The initiative is made possible through funding by Google co-founder
Mr. Brin’s personal donation substantially underwrites the cost of genotyping the participants, who will pay only
The company plans to announce similar initiatives around other diseases. “Our approach of combining genetic data with the web-based collection of condition-specific information has the potential to drive the study of many disorders,” said 23andMe co-founder
23andMe, Inc. is a leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company’s Personal Genome Service(TM) enables individuals to gain deeper insights into their ancestry and inherited traits. 23andMe, Inc., was founded by
Founded in 2000, The Michael J. Fox Foundation for Parkinson’s Research is dedicated to ensuring the development of a cure for Parkinson’s disease within the coming decade through an aggressively funded research agenda. The Foundation has funded nearly
Founded in 1988, The Parkinson’s Institute and Clinical Center (PI) is America’s only independent non-profit organization that provides basic and clinical research, clinical trials and a comprehensive movement disorder patient clinic for Parkinson’s disease (PD) and related neurological movement disorders, all under one roof. Its mission is to find the causes, provide first class patient care and discover a cure. This unique freestanding organization supports a strong collaboration of translational medicine designed to more directly connect research to patient care – from the “bench to bedside.” For more information visit http://www.thepi.org.
SOURCE 23andMe, Inc.